UNIGE document Scientific Article
previous document  unige:128231  next document
add to browser collection

Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer

Minicozzi, Pamela
Van Eycken, Liesbet
Molinie, Florence
Innos, Kaire
Guevara, Marcela
Marcos-Gragera, Rafael
Castro, Clara
show hidden authors show all authors [1 - 17]
Published in International Journal of Cancer. 2019, vol. 144, no. 9, p. 2118-2127
Abstract Survival for breast cancer (BC) is lower in eastern than northern/central Europe, and in older than younger women. We analysed how comorbidities at diagnosis affected whether selected standard treatments (STs) were given, across Europe and over time, also assessing consequences for survival/relapse. We analysed 7581 stage I/IIA cases diagnosed in 9 European countries in 2009-2013, and 4 STs: surgery; breast-conserving surgery plus radiotherapy (BCS + RT); reconstruction after mastectomy; and prompt treatment (≤6 weeks after diagnosis). Covariate-adjusted models estimated odds of receiving STs and risks of death/relapse, according to comorbidities. Pearson's R assessed correlations between odds and risks. The z-test assessed the significance of time-trends. Most women received surgery: 72% BCS; 24% mastectomy. Mastectomied patients were older with more comorbidities than BCS patients (p < 0.001). Women given breast reconstruction (25% of mastectomies) were younger with fewer comorbidities than those without reconstruction (p < 0.001). Women treated promptly (45%) were younger than those treated later (p = 0.001), and more often without comorbidities (p < 0.001). Receiving surgery/BCS + RT correlated strongly (R = -0.9), but prompt treatment weakly (R = -0.01/-0.02), with reduced death/relapse risks. The proportion receiving BCS + RT increased significantly (p < 0.001) with time in most countries. This appears to be the first analysis of the influence of comorbidities on receiving STs, and of consequences for outcomes. Increase in BCS + RT with time is encouraging. Although women without comorbidities usually received STs, elderly patients often received non-standard less prompt treatments, irrespective of comorbidities, with increased risk of mortality/relapse. All women, particularly the elderly, should receive ST wherever possible to maximise the benefits of modern evidence-based treatments.
Keywords AdolescentAdultAge FactorsAgedBreast Neoplasms/mortality/pathology/therapyCombined Modality Therapy/statistics & numerical dataComorbidityEuropeFemaleHumansMammaplasty/statistics & numerical dataMastectomySegmental/statistics & numerical dataMiddle AgedRadiotherapyAdjuvantTime-to-Treatment/statistics & numerical dataTreatment OutcomeYoung Adult
PMID: 30411340
Full text
Article (Published version) (115 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Epidémiologie des tumeurs (1017)
Groupe Bouchardy Magnin Christine (Registre genevois des tumeurs) (532)
(ISO format)
MINICOZZI, Pamela et al. Comorbidities, age and period of diagnosis influence treatment and outcomes in early breast cancer. In: International Journal of Cancer, 2019, vol. 144, n° 9, p. 2118-2127. doi: 10.1002/ijc.31974 https://archive-ouverte.unige.ch/unige:128231

182 hits

0 download


Deposited on : 2020-01-06

Export document
Format :
Citation style :